Teva Pharmaceutical Indus... (TEVA)
NYSE: TEVA
· Real-Time Price · USD
18.95
0.47 (2.54%)
At close: Sep 05, 2025, 3:59 PM
18.95
0.00%
After-hours: Sep 05, 2025, 07:47 PM EDT
Teva Pharmaceutical Industries Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Distribution Service Revenue | 377M | 384M | 804M | 390M | 382M | 402M | 377M | 402M | 434M | 460M | 383M | 318M | 358M | 374M | 378M | 330M | 308M | 330M | 350M | 381M | 434M |
| Distribution Service Revenue Growth | -1.82% | -52.24% | +106.15% | +2.09% | -4.98% | +6.63% | -6.22% | -7.37% | -5.65% | +20.10% | +20.44% | -11.17% | -4.28% | -1.06% | +14.55% | +7.14% | -6.67% | -5.71% | -8.14% | -12.21% | n/a |
| License Revenue | 46M | 36M | 92M | 45M | 36M | 547M | 53M | 38M | 43M | 50M | 52M | 72M | 38M | 54M | 38M | 19M | 49M | 39M | 27M | 22M | 41M |
| License Revenue Growth | +27.78% | -60.87% | +104.44% | +25.00% | -93.42% | +932.08% | +39.47% | -11.63% | -14.00% | -3.85% | -27.78% | +89.47% | -29.63% | +42.11% | +100.00% | -61.22% | +25.64% | +44.44% | +22.73% | -46.34% | n/a |
| Product and Service, Other Revenue | 117M | 76M | 157M | 102M | 106M | 252M | 117M | 106M | 95M | 54M | 139M | 106M | 129M | 112M | 130M | 96M | 162M | 138M | 174M | 141M | 227M |
| Product and Service, Other Revenue Growth | +53.95% | -51.59% | +53.92% | -3.77% | -57.94% | +115.38% | +10.38% | +11.58% | +75.93% | -61.15% | +31.13% | -17.83% | +15.18% | -13.85% | +35.42% | -40.74% | +17.39% | -20.69% | +23.40% | -37.89% | n/a |
| Product Revenue | 3.64B | 3.4B | 7B | 3.79B | 3.64B | 3.25B | 3.3B | 3.33B | 3.09B | 3.32B | 3.02B | 3.29B | 3.14B | 3.56B | 3.34B | 3.46B | 3.46B | 3.95B | 3.43B | 3.33B | 3.65B |
| Product Revenue Growth | +7.10% | -51.47% | +84.40% | +4.23% | +11.83% | -1.45% | -0.84% | +7.80% | -6.93% | +9.90% | -8.15% | +4.88% | -11.93% | +6.62% | -3.61% | +0.06% | -12.24% | +15.14% | +3.04% | -9.00% | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Europe Segment Revenue | 1.3B | 1.19B | 2.63B | 1.26B | 1.21B | 1.34B | 1.15B | 1.16B | 1.18B | 1.13B | 1.07B | 1.17B | 1.16B | 1.27B | 1.22B | 1.18B | 1.21B | 1.24B | 1.12B | 1B | 1.4B |
| Europe Segment Revenue Growth | +8.71% | -54.51% | +107.51% | +4.29% | -9.75% | +17.28% | -1.46% | -1.77% | +4.87% | +5.61% | -8.71% | +1.30% | -8.83% | +3.93% | +3.04% | -2.47% | -1.94% | +10.93% | +11.49% | -28.60% | n/a |
| International Markets Revenue | 495M | 582M | 1.26B | 613M | 593M | 502M | 485M | 479M | 492M | 482M | 475M | 454M | 492M | 488M | 569M | 485M | 490M | 572M | 529M | 488M | 565M |
| International Markets Revenue Growth | -14.95% | -53.70% | +105.06% | +3.37% | +18.13% | +3.51% | +1.25% | -2.64% | +2.07% | +1.47% | +4.63% | -7.72% | +0.82% | -14.24% | +17.32% | -1.02% | -14.34% | +8.13% | +8.40% | -13.63% | n/a |
| United States Segment Revenue | 2.15B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Segment Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 959M | 919M | 952M | 924M | 939M | 886M | 902M | 844M | 910M | 842M | 838M | 822M | 907M | 880M | 908M | 888M | 857M | 875M | 1.01B | 884M | 861M | 917M | 1.02B | 880M | 962M | 940M | 1.14B | 1.05B | 1.03B | 1.1B | 1.36B | 1.19B | 1.23B | 1.21B | 1.44B | 1.25B | 1.26B | 1.14B | 1.21B | 1.1B | 1.19B | 1.23B |
| Selling, General, and Administrative Revenue Growth | +4.35% | -3.47% | +3.03% | -1.60% | +5.98% | -1.77% | +6.87% | -7.25% | +8.08% | +0.48% | +1.95% | -9.37% | +3.07% | -3.08% | +2.25% | +3.62% | -2.06% | -13.37% | +14.25% | +2.67% | -6.11% | -10.45% | +16.36% | -8.52% | +2.34% | -17.62% | +8.46% | +2.53% | -6.73% | -18.94% | +14.03% | -3.41% | +2.07% | -16.18% | +15.20% | -1.03% | +10.50% | -5.30% | +10.13% | -7.51% | -3.58% | n/a |
| Research and Development Revenue | 244M | 247M | 248M | 240M | 269M | 242M | 227M | 253M | 240M | 234M | 210M | 175M | 228M | 225M | 244M | 222M | 248M | 254M | 293M | 258M | 225M | 221M | 232M | 240M | 276M | 261M | 295M | 311M | 290M | 317M | 360M | 545M | 486M | 457M | 684M | 663M | 375M | 389M | 446M | 361M | 386M | 332M |
| Research and Development Revenue Growth | -1.21% | -0.40% | +3.33% | -10.78% | +11.16% | +6.61% | -10.28% | +5.42% | +2.56% | +11.43% | +20.00% | -23.25% | +1.33% | -7.79% | +9.91% | -10.48% | -2.36% | -13.31% | +13.57% | +14.67% | +1.81% | -4.74% | -3.33% | -13.04% | +5.75% | -11.53% | -5.14% | +7.24% | -8.52% | -11.94% | -33.94% | +12.14% | +6.35% | -33.19% | +3.17% | +76.80% | -3.60% | -12.78% | +23.55% | -6.48% | +16.27% | n/a |
| Sales and Marketing Revenue | 654M | 622M | 650M | 626M | 656M | 608M | 610M | 576M | 603M | 546M | 549M | 539M | 594M | 584M | 632M | 597M | 615M | 585M | 683M | 605M | 597M | 613M | 706M | 595M | 666M | 648M | 797M | 743M | 710M | 771M | 865M | 860M | 960M | 971M | 1.13B | 940M | 952M | 839M | 916M | 780M | 860M | 922M |
| Sales and Marketing Revenue Growth | +5.14% | -4.31% | +3.83% | -4.57% | +7.89% | -0.33% | +5.90% | -4.48% | +10.44% | -0.55% | +1.86% | -9.26% | +1.71% | -7.59% | +5.86% | -2.93% | +5.13% | -14.35% | +12.89% | +1.34% | -2.61% | -13.17% | +18.66% | -10.66% | +2.78% | -18.70% | +7.27% | +4.65% | -7.91% | -10.87% | +0.58% | -10.42% | -1.13% | -13.99% | +20.11% | -1.26% | +13.47% | -8.41% | +17.44% | -9.30% | -6.72% | n/a |